JANUMET is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Remedyrepack Inc.. The primary component is Sitagliptin Phosphate; Metformin Hydrochloride.
Product ID | 70518-2548_9c9f759b-9816-70dd-e053-2995a90a395c |
NDC | 70518-2548 |
Product Type | Human Prescription Drug |
Proprietary Name | JANUMET |
Generic Name | Sitagliptin And Metformin Hydrochloride |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 2020-01-20 |
Marketing Category | NDA / NDA |
Application Number | NDA022044 |
Labeler Name | REMEDYREPACK INC. |
Substance Name | SITAGLIPTIN PHOSPHATE; METFORMIN HYDROCHLORIDE |
Active Ingredient Strength | 50 mg/1; mg/1 |
Pharm Classes | Dipeptidyl Peptidase 4 Inhibitor [EPC],Dipeptidyl Peptidase 4 Inhibitors [MoA],Biguanide [EPC],Biguanides [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 2020-01-20 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA022044 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2020-01-20 |
Ingredient | Strength |
---|---|
SITAGLIPTIN PHOSPHATE | 50 mg/1 |
NDC | Brand Name | Generic Name |
---|---|---|
0006-0078 | JANUMET | sitagliptin and metformin hydrochloride |
0006-0080 | JANUMET | sitagliptin and metformin hydrochloride |
0006-0081 | JANUMET | sitagliptin and metformin hydrochloride |
0006-0575 | JANUMET | SITAGLIPTIN and METFORMIN HYDROCHLORIDE |
0006-0577 | JANUMET | SITAGLIPTIN and METFORMIN HYDROCHLORIDE |
50090-4411 | JANUMET | sitagliptin and metformin hydrochloride |
50090-5618 | JANUMET | SITAGLIPTIN and METFORMIN HYDROCHLORIDE |
70518-2548 | JANUMET | SITAGLIPTIN and METFORMIN HYDROCHLORIDE |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
JANUMET 78934999 3363805 Live/Registered |
MERCK SHARP & DOHME CORP. 2006-07-21 |
JANUMET 78773912 3374065 Live/Registered |
MERCK SHARP & DOHME CORP. 2005-12-15 |